Trial Identifier: | D9480C00014 |
Sponsor: | AstraZeneca |
NCTID:: | NCT04997161 |
Start Date: | August 2021 |
Primary Completion Date: | November 2021 |
Study Completion Date: | November 2021 |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
Language | Description |
English Version |
Country | Location |
---|---|
GB | Bradford, GB, BD9 6RJ |
GB | Hull, GB, HU32JZ |
GB | Leicester, GB, LE1 5WW |
GB | LONDON, GB, E1 1BB |
GB | Manchester, GB, M13 9WL |
GB | York, GB, YO31 8HE |
US, CA | Torrance, CA, US, 90502 |
US, CA | Victorville, CA, US, 92394 |
US, CT | Hartford, CT, US, 06112 |
US, CT | Middlebury, CT, US, 06762 |
US, FL | Lauderdale Lakes, FL, US, 33313 |
US, FL | West Palm Beach, FL, US, 33411 |
US, MA | Springfield, MA, US, 01107 |
US, NV | Las Vegas, NV, US, 89128 |
US, NY | Bronx, NY, US, 10461 |
US, TN | Knoxville, TN, US, 37923 |
US, TX | Conroe, TX, US, 77384 |
US, TX | El Paso, TX, US, 79936 |
US, TX | Houston, TX, US, 77054 |
US, TX | Houston, TX, US, 77004 |
US, TX | San Antonio, TX, US, 78251 |
US, VA | Norfolk, VA, US, 23502 |
US, WI | Milwaukee, WI, US, 53226 |